These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. At-Home Versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS). Phibbs CS; Love SR; Jacobson AK; Edson R; Su P; Uyeda L; Matchar DB; J Gen Intern Med; 2016 Sep; 31(9):1061-7. PubMed ID: 27234663 [TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Connock M; Stevens C; Fry-Smith A; Jowett S; Fitzmaurice D; Moore D; Song F Health Technol Assess; 2007 Oct; 11(38):iii-iv, ix-66. PubMed ID: 17903392 [TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis. Niyomsri S; Nimworapan M; Wongcharoen W; Dilokthornsakul P Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833871 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: a cost-effectiveness analysis. You JH Pharmacogenet Genomics; 2014 Jan; 24(1):6-14. PubMed ID: 24168919 [TBL] [Abstract][Full Text] [Related]
8. Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore. Chua WB; Cheen HH; Kong MC; Chen LL; Wee HL Int J Clin Pharm; 2016 Oct; 38(5):1230-40. PubMed ID: 27461367 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand. Ng SS; Nathisuwan S; Phrommintikul A; Chaiyakunapruk N Thromb Res; 2020 Jan; 185():63-71. PubMed ID: 31770689 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of a randomized controlled trial of pharmacist-supervized patient self-testing of warfarin therapy. Gallagher J; Mc Carthy S; Woods N; Ryan F; O' Shea S; Byrne S J Clin Pharm Ther; 2015 Feb; 40(1):14-9. PubMed ID: 25295834 [TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients. Nguyen E; Egri F; Mearns ES; White CM; Coleman CI Pharmacotherapy; 2016 May; 36(5):488-95. PubMed ID: 27015873 [TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses. Li X; Tse VC; Lau WC; Cheung BM; Lip GY; Wong IC; Chan EW PLoS One; 2016; 11(6):e0157129. PubMed ID: 27362421 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570 [TBL] [Abstract][Full Text] [Related]
14. Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand. Permsuwan U; Thongprasert S; Sirichanchuen B Value Health Reg Issues; 2020 May; 21():9-16. PubMed ID: 31634796 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: a U.S. perspective. Seaman CD; Smith KJ; Ragni MV Thromb Res; 2013; 132(6):647-51. PubMed ID: 24139508 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption. Nutescu EA; Bathija S; Sharp LK; Gerber BS; Schumock GT; Fitzgibbon ML Pharmacotherapy; 2011 Dec; 31(12):1161-74. PubMed ID: 22122179 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation: a cost-effectiveness analysis from a U.S. perspective. Pishko AM; Smith KJ; Ragni MV Thromb Haemost; 2012 Aug; 108(2):303-10. PubMed ID: 22627904 [TBL] [Abstract][Full Text] [Related]
18. Cost-Utility of Video-Electroencephalography Monitoring Followed by Surgery in Adults with Drug-Resistant Focal Epilepsy in Thailand. Kitwitee P; Unnwongse K; Srikijvilaikul T; Yadee T; Limwattananon C World Neurosurg; 2017 Feb; 98():750-760.e3. PubMed ID: 27913266 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Bloomfield HE; Krause A; Greer N; Taylor BC; MacDonald R; Rutks I; Reddy P; Wilt TJ Ann Intern Med; 2011 Apr; 154(7):472-82. PubMed ID: 21464349 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population. Saokaew S; Tassaneeyakul W; Maenthaisong R; Chaiyakunapruk N PLoS One; 2014; 9(4):e94294. PubMed ID: 24732692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]